1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Abnormalities, Multiple in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Govaerts, LC; Heymans, HS; Prins, A; Schaap, MC; Schutgens, RB; Sturk, A; ten Cate, JW; Wanders, RJ | 1 |
| Borst, P; Heymans, HS; Przyrembel, H; Schaap, MC; Schutgens, RB; Sturk, A; ten Cate, JW | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Abnormalities, Multiple
| Article | Year |
|---|---|
Age-related deficiency of the synthesis of platelet activating factor by leukocytes from Zellweger patients.
Topics: Abnormalities, Multiple; Aging; Brain; Erythrocytes; Humans; Kidney; Leukocytes; Liver; Phosphatidylethanolamines; Platelet Activating Factor; Syndrome | 1987 |
Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.
Topics: Abnormalities, Multiple; Brain; Female; Humans; In Vitro Techniques; Infant; Infant, Newborn; Kidney; Leukocytes; Liver; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Thrombin | 1987 |